nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—CYP1A2—Carmustine—lymphatic system cancer	0.0419	0.47	CbGbCtD
Asenapine—Localized exfoliation—Bleomycin—lymphatic system cancer	0.0341	0.0375	CcSEcCtD
Asenapine—Blister—Mechlorethamine—lymphatic system cancer	0.0269	0.0295	CcSEcCtD
Asenapine—Amenorrhoea—Mechlorethamine—lymphatic system cancer	0.022	0.0242	CcSEcCtD
Asenapine—Sinus bradycardia—Mitoxantrone—lymphatic system cancer	0.0152	0.0167	CcSEcCtD
Asenapine—CYP3A4—Cytarabine—lymphatic system cancer	0.015	0.168	CbGbCtD
Asenapine—CYP3A4—Teniposide—lymphatic system cancer	0.0148	0.166	CbGbCtD
Asenapine—Dermatitis bullous—Mechlorethamine—lymphatic system cancer	0.0147	0.0161	CcSEcCtD
Asenapine—Depression—Mechlorethamine—lymphatic system cancer	0.0108	0.0119	CcSEcCtD
Asenapine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0103	0.116	CbGbCtD
Asenapine—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.0101	0.0111	CcSEcCtD
Asenapine—Ulcer—Bleomycin—lymphatic system cancer	0.00972	0.0107	CcSEcCtD
Asenapine—Wheezing—Bleomycin—lymphatic system cancer	0.00893	0.0098	CcSEcCtD
Asenapine—Skin exfoliation—Bleomycin—lymphatic system cancer	0.00878	0.00964	CcSEcCtD
Asenapine—Amenorrhoea—Mitoxantrone—lymphatic system cancer	0.00849	0.00932	CcSEcCtD
Asenapine—Neutropenia—Teniposide—lymphatic system cancer	0.00837	0.00919	CcSEcCtD
Asenapine—Pulmonary embolism—Carmustine—lymphatic system cancer	0.00803	0.00881	CcSEcCtD
Asenapine—Ulcer—Mitoxantrone—lymphatic system cancer	0.00789	0.00866	CcSEcCtD
Asenapine—Dysphagia—Fludarabine—lymphatic system cancer	0.00787	0.00864	CcSEcCtD
Asenapine—Stomatitis—Teniposide—lymphatic system cancer	0.00778	0.00854	CcSEcCtD
Asenapine—Skin exfoliation—Carmustine—lymphatic system cancer	0.00766	0.00841	CcSEcCtD
Asenapine—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00757	0.00832	CcSEcCtD
Asenapine—Neutropenia—Fludarabine—lymphatic system cancer	0.00736	0.00808	CcSEcCtD
Asenapine—Gynaecomastia—Carmustine—lymphatic system cancer	0.00718	0.00788	CcSEcCtD
Asenapine—CYP3A4—Vincristine—lymphatic system cancer	0.00711	0.0797	CbGbCtD
Asenapine—Hyperglycaemia—Fludarabine—lymphatic system cancer	0.0071	0.00779	CcSEcCtD
Asenapine—Mouth ulceration—Vincristine—lymphatic system cancer	0.00693	0.00761	CcSEcCtD
Asenapine—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00691	0.00758	CcSEcCtD
Asenapine—Stomatitis—Fludarabine—lymphatic system cancer	0.00684	0.00751	CcSEcCtD
Asenapine—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00676	0.00742	CcSEcCtD
Asenapine—Diabetes mellitus—Carmustine—lymphatic system cancer	0.0067	0.00735	CcSEcCtD
Asenapine—Swelling—Carmustine—lymphatic system cancer	0.0066	0.00725	CcSEcCtD
Asenapine—Swelling—Mitoxantrone—lymphatic system cancer	0.00614	0.00674	CcSEcCtD
Asenapine—Hyponatraemia—Carmustine—lymphatic system cancer	0.00585	0.00642	CcSEcCtD
Asenapine—Anaemia—Teniposide—lymphatic system cancer	0.00577	0.00633	CcSEcCtD
Asenapine—Agitation—Teniposide—lymphatic system cancer	0.00573	0.00629	CcSEcCtD
Asenapine—Anaphylactoid reaction—Mitoxantrone—lymphatic system cancer	0.0056	0.00614	CcSEcCtD
Asenapine—Hyponatraemia—Vincristine—lymphatic system cancer	0.00558	0.00613	CcSEcCtD
Asenapine—Leukopenia—Teniposide—lymphatic system cancer	0.00558	0.00613	CcSEcCtD
Asenapine—Pain in extremity—Vincristine—lymphatic system cancer	0.00556	0.00611	CcSEcCtD
Asenapine—Malnutrition—Fludarabine—lymphatic system cancer	0.00548	0.00602	CcSEcCtD
Asenapine—Hyponatraemia—Mitoxantrone—lymphatic system cancer	0.00544	0.00597	CcSEcCtD
Asenapine—Hypertension—Teniposide—lymphatic system cancer	0.00539	0.00591	CcSEcCtD
Asenapine—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00509	0.00559	CcSEcCtD
Asenapine—Anaemia—Fludarabine—lymphatic system cancer	0.00507	0.00556	CcSEcCtD
Asenapine—Agitation—Fludarabine—lymphatic system cancer	0.00504	0.00553	CcSEcCtD
Asenapine—Dysphagia—Carmustine—lymphatic system cancer	0.00504	0.00553	CcSEcCtD
Asenapine—Stomatitis—Bleomycin—lymphatic system cancer	0.00501	0.0055	CcSEcCtD
Asenapine—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00499	0.00547	CcSEcCtD
Asenapine—Tachycardia—Teniposide—lymphatic system cancer	0.00497	0.00546	CcSEcCtD
Asenapine—Malaise—Fludarabine—lymphatic system cancer	0.00494	0.00543	CcSEcCtD
Asenapine—Leukopenia—Fludarabine—lymphatic system cancer	0.00491	0.00539	CcSEcCtD
Asenapine—Alanine aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.00478	0.00525	CcSEcCtD
Asenapine—Hypotension—Teniposide—lymphatic system cancer	0.00476	0.00522	CcSEcCtD
Asenapine—Convulsion—Fludarabine—lymphatic system cancer	0.00475	0.00522	CcSEcCtD
Asenapine—Neutropenia—Carmustine—lymphatic system cancer	0.00471	0.00517	CcSEcCtD
Asenapine—Arthralgia—Fludarabine—lymphatic system cancer	0.00467	0.00512	CcSEcCtD
Asenapine—Hyperglycaemia—Carmustine—lymphatic system cancer	0.00454	0.00499	CcSEcCtD
Asenapine—Dyspnoea—Teniposide—lymphatic system cancer	0.00454	0.00498	CcSEcCtD
Asenapine—Neutropenia—Vincristine—lymphatic system cancer	0.0045	0.00494	CcSEcCtD
Asenapine—Depression—Carmustine—lymphatic system cancer	0.00448	0.00492	CcSEcCtD
Asenapine—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00447	0.00491	CcSEcCtD
Asenapine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00439	0.00482	CcSEcCtD
Asenapine—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00439	0.00482	CcSEcCtD
Asenapine—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00438	0.00481	CcSEcCtD
Asenapine—Neutropenia—Mitoxantrone—lymphatic system cancer	0.00438	0.00481	CcSEcCtD
Asenapine—Stomatitis—Carmustine—lymphatic system cancer	0.00438	0.00481	CcSEcCtD
Asenapine—Rash—Mechlorethamine—lymphatic system cancer	0.00435	0.00478	CcSEcCtD
Asenapine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00435	0.00478	CcSEcCtD
Asenapine—Depression—Vincristine—lymphatic system cancer	0.00427	0.00469	CcSEcCtD
Asenapine—Weight increased—Mitoxantrone—lymphatic system cancer	0.00426	0.00468	CcSEcCtD
Asenapine—Hyperglycaemia—Mitoxantrone—lymphatic system cancer	0.00422	0.00464	CcSEcCtD
Asenapine—Stomatitis—Vincristine—lymphatic system cancer	0.00418	0.00459	CcSEcCtD
Asenapine—Nausea—Mechlorethamine—lymphatic system cancer	0.0041	0.0045	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00408	0.00448	CcSEcCtD
Asenapine—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00407	0.00447	CcSEcCtD
Asenapine—Dyspnoea—Fludarabine—lymphatic system cancer	0.00399	0.00438	CcSEcCtD
Asenapine—Oedema peripheral—Carmustine—lymphatic system cancer	0.00397	0.00436	CcSEcCtD
Asenapine—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00396	0.00435	CcSEcCtD
Asenapine—Dyspepsia—Fludarabine—lymphatic system cancer	0.00394	0.00432	CcSEcCtD
Asenapine—Ulcer—Methotrexate—lymphatic system cancer	0.00393	0.00432	CcSEcCtD
Asenapine—Dysarthria—Methotrexate—lymphatic system cancer	0.00393	0.00432	CcSEcCtD
Asenapine—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.0039	0.00428	CcSEcCtD
Asenapine—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00386	0.00424	CcSEcCtD
Asenapine—Fatigue—Fludarabine—lymphatic system cancer	0.00386	0.00424	CcSEcCtD
Asenapine—Inflammation—Methotrexate—lymphatic system cancer	0.00383	0.00421	CcSEcCtD
Asenapine—Constipation—Fludarabine—lymphatic system cancer	0.00383	0.0042	CcSEcCtD
Asenapine—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00378	0.00415	CcSEcCtD
Asenapine—Eye disorder—Carmustine—lymphatic system cancer	0.00377	0.00414	CcSEcCtD
Asenapine—Hypersensitivity—Teniposide—lymphatic system cancer	0.00375	0.00412	CcSEcCtD
Asenapine—Pulmonary embolism—Methotrexate—lymphatic system cancer	0.00372	0.00408	CcSEcCtD
Asenapine—Anaemia—Bleomycin—lymphatic system cancer	0.00372	0.00408	CcSEcCtD
Asenapine—Asthenia—Teniposide—lymphatic system cancer	0.00365	0.00401	CcSEcCtD
Asenapine—Malaise—Bleomycin—lymphatic system cancer	0.00363	0.00398	CcSEcCtD
Asenapine—Leukopenia—Bleomycin—lymphatic system cancer	0.0036	0.00395	CcSEcCtD
Asenapine—Cardiac disorder—Vincristine—lymphatic system cancer	0.00357	0.00392	CcSEcCtD
Asenapine—Skin exfoliation—Methotrexate—lymphatic system cancer	0.00355	0.0039	CcSEcCtD
Asenapine—Mental disorder—Carmustine—lymphatic system cancer	0.00353	0.00388	CcSEcCtD
Asenapine—Malnutrition—Carmustine—lymphatic system cancer	0.00351	0.00385	CcSEcCtD
Asenapine—Angiopathy—Vincristine—lymphatic system cancer	0.00349	0.00383	CcSEcCtD
Asenapine—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00347	0.00381	CcSEcCtD
Asenapine—Mental disorder—Vincristine—lymphatic system cancer	0.00337	0.0037	CcSEcCtD
Asenapine—Mouth ulceration—Methotrexate—lymphatic system cancer	0.00336	0.00369	CcSEcCtD
Asenapine—Gynaecomastia—Methotrexate—lymphatic system cancer	0.00333	0.00365	CcSEcCtD
Asenapine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.0033	0.00362	CcSEcCtD
Asenapine—Tremor—Carmustine—lymphatic system cancer	0.00329	0.00361	CcSEcCtD
Asenapine—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00328	0.0036	CcSEcCtD
Asenapine—Anaemia—Carmustine—lymphatic system cancer	0.00324	0.00356	CcSEcCtD
Asenapine—Vomiting—Teniposide—lymphatic system cancer	0.00324	0.00355	CcSEcCtD
Asenapine—Agitation—Carmustine—lymphatic system cancer	0.00322	0.00354	CcSEcCtD
Asenapine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00321	0.00353	CcSEcCtD
Asenapine—Asthenia—Fludarabine—lymphatic system cancer	0.00321	0.00352	CcSEcCtD
Asenapine—Rash—Teniposide—lymphatic system cancer	0.00321	0.00352	CcSEcCtD
Asenapine—Dermatitis—Teniposide—lymphatic system cancer	0.00321	0.00352	CcSEcCtD
Asenapine—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00319	0.00351	CcSEcCtD
Asenapine—Headache—Teniposide—lymphatic system cancer	0.00319	0.0035	CcSEcCtD
Asenapine—Leukopenia—Carmustine—lymphatic system cancer	0.00314	0.00345	CcSEcCtD
Asenapine—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.0031	0.00341	CcSEcCtD
Asenapine—Anaemia—Vincristine—lymphatic system cancer	0.0031	0.0034	CcSEcCtD
Asenapine—Agitation—Vincristine—lymphatic system cancer	0.00308	0.00338	CcSEcCtD
Asenapine—Hypotension—Bleomycin—lymphatic system cancer	0.00307	0.00337	CcSEcCtD
Asenapine—Convulsion—Carmustine—lymphatic system cancer	0.00304	0.00334	CcSEcCtD
Asenapine—Hypertension—Carmustine—lymphatic system cancer	0.00303	0.00333	CcSEcCtD
Asenapine—Nausea—Teniposide—lymphatic system cancer	0.00302	0.00332	CcSEcCtD
Asenapine—Anaemia—Mitoxantrone—lymphatic system cancer	0.00302	0.00331	CcSEcCtD
Asenapine—Leukopenia—Vincristine—lymphatic system cancer	0.003	0.00329	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00299	0.00328	CcSEcCtD
Asenapine—Anxiety—Carmustine—lymphatic system cancer	0.00298	0.00327	CcSEcCtD
Asenapine—Malaise—Mitoxantrone—lymphatic system cancer	0.00294	0.00323	CcSEcCtD
Asenapine—Dyspnoea—Bleomycin—lymphatic system cancer	0.00293	0.00321	CcSEcCtD
Asenapine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00292	0.00321	CcSEcCtD
Asenapine—Convulsion—Vincristine—lymphatic system cancer	0.0029	0.00319	CcSEcCtD
Asenapine—Hypertension—Vincristine—lymphatic system cancer	0.00289	0.00318	CcSEcCtD
Asenapine—Vomiting—Fludarabine—lymphatic system cancer	0.00285	0.00312	CcSEcCtD
Asenapine—Convulsion—Mitoxantrone—lymphatic system cancer	0.00283	0.0031	CcSEcCtD
Asenapine—Rash—Fludarabine—lymphatic system cancer	0.00282	0.0031	CcSEcCtD
Asenapine—Dermatitis—Fludarabine—lymphatic system cancer	0.00282	0.00309	CcSEcCtD
Asenapine—Hypertension—Mitoxantrone—lymphatic system cancer	0.00282	0.00309	CcSEcCtD
Asenapine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.0028	0.00308	CcSEcCtD
Asenapine—Headache—Fludarabine—lymphatic system cancer	0.0028	0.00308	CcSEcCtD
Asenapine—Tachycardia—Carmustine—lymphatic system cancer	0.0028	0.00307	CcSEcCtD
Asenapine—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.00279	0.00306	CcSEcCtD
Asenapine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00278	0.00305	CcSEcCtD
Asenapine—Anxiety—Mitoxantrone—lymphatic system cancer	0.00277	0.00304	CcSEcCtD
Asenapine—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00273	0.003	CcSEcCtD
Asenapine—Osteoarthritis—Methotrexate—lymphatic system cancer	0.0027	0.00296	CcSEcCtD
Asenapine—Nervous system disorder—Vincristine—lymphatic system cancer	0.00268	0.00294	CcSEcCtD
Asenapine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00268	0.00294	CcSEcCtD
Asenapine—Hypotension—Carmustine—lymphatic system cancer	0.00268	0.00294	CcSEcCtD
Asenapine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00266	0.00292	CcSEcCtD
Asenapine—Nausea—Fludarabine—lymphatic system cancer	0.00266	0.00292	CcSEcCtD
Asenapine—Shock—Mitoxantrone—lymphatic system cancer	0.00262	0.00288	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00261	0.00286	CcSEcCtD
Asenapine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00261	0.00286	CcSEcCtD
Asenapine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.0026	0.00285	CcSEcCtD
Asenapine—Insomnia—Carmustine—lymphatic system cancer	0.00259	0.00284	CcSEcCtD
Asenapine—Irritability—Methotrexate—lymphatic system cancer	0.00258	0.00283	CcSEcCtD
Asenapine—Hypotension—Vincristine—lymphatic system cancer	0.00255	0.0028	CcSEcCtD
Asenapine—Dyspnoea—Carmustine—lymphatic system cancer	0.00255	0.0028	CcSEcCtD
Asenapine—Somnolence—Carmustine—lymphatic system cancer	0.00255	0.0028	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00249	0.00273	CcSEcCtD
Asenapine—Hypotension—Mitoxantrone—lymphatic system cancer	0.00249	0.00273	CcSEcCtD
Asenapine—Insomnia—Vincristine—lymphatic system cancer	0.00247	0.00271	CcSEcCtD
Asenapine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00247	0.00271	CcSEcCtD
Asenapine—Constipation—Carmustine—lymphatic system cancer	0.00245	0.00269	CcSEcCtD
Asenapine—Breast disorder—Methotrexate—lymphatic system cancer	0.00244	0.00268	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00243	0.00266	CcSEcCtD
Asenapine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00242	0.00265	CcSEcCtD
Asenapine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00237	0.00261	CcSEcCtD
Asenapine—Somnolence—Mitoxantrone—lymphatic system cancer	0.00237	0.0026	CcSEcCtD
Asenapine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00236	0.00259	CcSEcCtD
Asenapine—Fatigue—Vincristine—lymphatic system cancer	0.00236	0.00259	CcSEcCtD
Asenapine—Asthenia—Bleomycin—lymphatic system cancer	0.00235	0.00258	CcSEcCtD
Asenapine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00234	0.00257	CcSEcCtD
Asenapine—Constipation—Vincristine—lymphatic system cancer	0.00234	0.00257	CcSEcCtD
Asenapine—Fatigue—Mitoxantrone—lymphatic system cancer	0.0023	0.00252	CcSEcCtD
Asenapine—Constipation—Mitoxantrone—lymphatic system cancer	0.00228	0.0025	CcSEcCtD
Asenapine—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00224	0.00246	CcSEcCtD
Asenapine—Neutropenia—Methotrexate—lymphatic system cancer	0.00218	0.00239	CcSEcCtD
Asenapine—Hypersensitivity—Carmustine—lymphatic system cancer	0.00211	0.00232	CcSEcCtD
Asenapine—Vomiting—Bleomycin—lymphatic system cancer	0.00209	0.00229	CcSEcCtD
Asenapine—Depression—Methotrexate—lymphatic system cancer	0.00207	0.00228	CcSEcCtD
Asenapine—Rash—Bleomycin—lymphatic system cancer	0.00207	0.00227	CcSEcCtD
Asenapine—Dermatitis—Bleomycin—lymphatic system cancer	0.00207	0.00227	CcSEcCtD
Asenapine—Asthenia—Carmustine—lymphatic system cancer	0.00205	0.00226	CcSEcCtD
Asenapine—Stomatitis—Methotrexate—lymphatic system cancer	0.00203	0.00223	CcSEcCtD
Asenapine—Hypersensitivity—Vincristine—lymphatic system cancer	0.00201	0.00221	CcSEcCtD
Asenapine—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00197	0.00216	CcSEcCtD
Asenapine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00196	0.00215	CcSEcCtD
Asenapine—Asthenia—Vincristine—lymphatic system cancer	0.00196	0.00215	CcSEcCtD
Asenapine—Nausea—Bleomycin—lymphatic system cancer	0.00195	0.00214	CcSEcCtD
Asenapine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00194	0.00213	CcSEcCtD
Asenapine—Asthenia—Mitoxantrone—lymphatic system cancer	0.00191	0.0021	CcSEcCtD
Asenapine—Dizziness—Carmustine—lymphatic system cancer	0.00189	0.00208	CcSEcCtD
Asenapine—Vomiting—Carmustine—lymphatic system cancer	0.00182	0.002	CcSEcCtD
Asenapine—Dizziness—Vincristine—lymphatic system cancer	0.00181	0.00198	CcSEcCtD
Asenapine—Rash—Carmustine—lymphatic system cancer	0.00181	0.00198	CcSEcCtD
Asenapine—Dermatitis—Carmustine—lymphatic system cancer	0.0018	0.00198	CcSEcCtD
Asenapine—Headache—Carmustine—lymphatic system cancer	0.00179	0.00197	CcSEcCtD
Asenapine—Eye disorder—Methotrexate—lymphatic system cancer	0.00174	0.00192	CcSEcCtD
Asenapine—Vomiting—Vincristine—lymphatic system cancer	0.00174	0.00191	CcSEcCtD
Asenapine—Cardiac disorder—Methotrexate—lymphatic system cancer	0.00173	0.0019	CcSEcCtD
Asenapine—Rash—Vincristine—lymphatic system cancer	0.00172	0.00189	CcSEcCtD
Asenapine—Dermatitis—Vincristine—lymphatic system cancer	0.00172	0.00189	CcSEcCtD
Asenapine—Headache—Vincristine—lymphatic system cancer	0.00171	0.00188	CcSEcCtD
Asenapine—Nausea—Carmustine—lymphatic system cancer	0.0017	0.00187	CcSEcCtD
Asenapine—Angiopathy—Methotrexate—lymphatic system cancer	0.00169	0.00186	CcSEcCtD
Asenapine—Vomiting—Mitoxantrone—lymphatic system cancer	0.00169	0.00186	CcSEcCtD
Asenapine—Immune system disorder—Methotrexate—lymphatic system cancer	0.00169	0.00185	CcSEcCtD
Asenapine—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.00168	0.00185	CcSEcCtD
Asenapine—Rash—Mitoxantrone—lymphatic system cancer	0.00168	0.00184	CcSEcCtD
Asenapine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00168	0.00184	CcSEcCtD
Asenapine—Headache—Mitoxantrone—lymphatic system cancer	0.00167	0.00183	CcSEcCtD
Asenapine—Mental disorder—Methotrexate—lymphatic system cancer	0.00164	0.0018	CcSEcCtD
Asenapine—Malnutrition—Methotrexate—lymphatic system cancer	0.00163	0.00178	CcSEcCtD
Asenapine—Nausea—Vincristine—lymphatic system cancer	0.00162	0.00178	CcSEcCtD
Asenapine—Dysgeusia—Methotrexate—lymphatic system cancer	0.00159	0.00175	CcSEcCtD
Asenapine—Nausea—Mitoxantrone—lymphatic system cancer	0.00158	0.00174	CcSEcCtD
Asenapine—Anaemia—Methotrexate—lymphatic system cancer	0.0015	0.00165	CcSEcCtD
Asenapine—Malaise—Methotrexate—lymphatic system cancer	0.00147	0.00161	CcSEcCtD
Asenapine—Leukopenia—Methotrexate—lymphatic system cancer	0.00145	0.0016	CcSEcCtD
Asenapine—Convulsion—Methotrexate—lymphatic system cancer	0.00141	0.00155	CcSEcCtD
Asenapine—Arthralgia—Methotrexate—lymphatic system cancer	0.00138	0.00152	CcSEcCtD
Asenapine—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00133	0.00146	CcSEcCtD
Asenapine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.0013	0.00143	CcSEcCtD
Asenapine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.0013	0.00143	CcSEcCtD
Asenapine—Hypotension—Methotrexate—lymphatic system cancer	0.00124	0.00136	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00121	0.00133	CcSEcCtD
Asenapine—Insomnia—Methotrexate—lymphatic system cancer	0.0012	0.00132	CcSEcCtD
Asenapine—Dyspnoea—Methotrexate—lymphatic system cancer	0.00118	0.0013	CcSEcCtD
Asenapine—Somnolence—Methotrexate—lymphatic system cancer	0.00118	0.00129	CcSEcCtD
Asenapine—Dyspepsia—Methotrexate—lymphatic system cancer	0.00117	0.00128	CcSEcCtD
Asenapine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00115	0.00126	CcSEcCtD
Asenapine—Fatigue—Methotrexate—lymphatic system cancer	0.00114	0.00126	CcSEcCtD
Asenapine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000977	0.00107	CcSEcCtD
Asenapine—Asthenia—Methotrexate—lymphatic system cancer	0.000952	0.00104	CcSEcCtD
Asenapine—Dizziness—Methotrexate—lymphatic system cancer	0.000877	0.000963	CcSEcCtD
Asenapine—Vomiting—Methotrexate—lymphatic system cancer	0.000843	0.000926	CcSEcCtD
Asenapine—Rash—Methotrexate—lymphatic system cancer	0.000836	0.000918	CcSEcCtD
Asenapine—Dermatitis—Methotrexate—lymphatic system cancer	0.000836	0.000917	CcSEcCtD
Asenapine—Headache—Methotrexate—lymphatic system cancer	0.000831	0.000912	CcSEcCtD
Asenapine—Nausea—Methotrexate—lymphatic system cancer	0.000788	0.000865	CcSEcCtD
